Doublecortin on X chromosome (DCX) is one of two major genetic loci underlying human lissencephaly, a neurodevelopmental disorder with defects in neuronal migration and axon outgrowth. DCX is a microtubule-binding protein, and much work has focused on its microtubule-associated functions. DCX has other reported binding partners, including the cell adhesion molecule neurofascin, but the functional significance of the DCX-neurofascin interaction is not understood. Neurofascin localizes strongly to the axon initial segment in mature neurons, where it plays a role in assembling and maintaining other axon initial segment components. During development, neurofascin likely plays additional roles in axon guidance and in GABAergic synaptogenesis. We show here that DCX can modulate the surface distribution of neurofascin in developing cultured rat neurons and thereby the relative extent of accumulation between the axon initial segment and soma and dendrites. Mechanistically, DCX acts via increasing endocytosis of neurofascin from soma and dendrites. Surprisingly, DCX increases neurofascin endocytosis apparently independently of its microtubule-binding activity. We additionally show that the patient allele DCXG253D still binds microtubules but is deficient in promoting neurofascin endocytosis. We propose that DCX acts as an endocytic adaptor for neurofascin to fine-tune its surface distribution during neuronal development.
Introduction
Many of the proteins crucial for neuronal functioning are spatially segregated to distinct functional domains (Horton and Ehlers, 2003; Salzer, 2003; Lasiecka et al., 2009) . During development, cell adhesion molecules such as the L1-CAM family members (L1, neurofascin, NrCAM) regulate axon outgrowth and are enriched on the growing axon (Maness and Schachner, 2007) . In addition, neurofascin (NF) and NrCAM are prominently enriched on and play roles at the axon initial segment (AIS) and Nodes of Ranvier at later times. NF is an essential gene, and knockout mice lack Nodes of Ranvier (Sherman et al., 2005) . Even though NF is not required for assembly of the AIS, it is necessary for maintaining it (Zonta et al., 2011) . NF plays additional roles during development, but these roles are less well understood. For instance, NF has been implicated in GABAergic synaptogenesis at the AIS (Ango et al., 2004; Burkarth et al., 2007; Kriebel et al., 2011) and can affect neurite outgrowth of cultured neurons (Volkmer et al., 1996; Pruss et al., 2004 Pruss et al., , 2006 .
It is well established that ankyrinG (ankG) anchors receptors at the AIS (for review, see Ogawa and Rasband, 2008) . For example, a point mutation in the FIGQY ankyrin-binding motif of NF led to loss of AIS localization (Boiko et al., 2007; Dzhashiashvili et al., 2007) . Importantly, the FIGQY motif bound strongly to ankyrinG only when nonphosphorylated (Tuvia et al., 1997; Zhang et al., 1998) . When phosphorylated downstream of neurotrophin signaling, the FIGQY motif bound to doublecortin (DCX) instead (Kizhatil et al., 2002) . DCX is mutated in patients with lissencephaly ("smooth brain"), a neurodevelopmental disease with layering defects in the cortex and hippocampus that result in cognitive deficits and epilepsy (des Portes et al., 1998; Gleeson et al., 1998) . In addition, DCX also functions in later stages of neurodevelopment (Friocourt et al., 2003; Schaar et al., 2004; Deuel et al., 2006; Kappeler et al., 2007) , such as axon and dendrite formation (Deuel et al., 2006; Cohen et al., 2008) . On the molecular level, DCX binds microtubules via binding interfaces contained within two doublecortin (DC) repeats. Interestingly, most of the known human mutations in DCX are contained within these repeats. The phenotypes associated with DCX mutations or depletion are therefore postulated to be due to impairment of microtubule-related functions Kim et al., 2003; Leger et al., 2008; Liu, 2011) . In addition to microtubule binding, DCX also binds several other proteins Tanaka et al., 2004) , such as clathrin adaptors (Friocourt et al., 2001 ) and NF (Kizhatil et al., 2002) . It is not known whether the interaction of DCX with NF affects either NF localization or function.
shRNA plasmids
To specifically knockdown the DCX protein expression, we used validated short hairpin (sh) RNA targeting the rat DCX sequences obtained from Super Array Bioscience. The shRNAs were expressed from the U1 promoter cassette of a pGeneclip hMGFP vector containing GFP under the regulation of the CMV promoter. The sequences of the four short hairpin RNA targeting the rat DCX were: shDCX#1: AGG CCA AGA AGG TAC GTT TCT; shDCX#2: TCA CCT GTC TCC ATG ATT TCT; shDCX#3: AAG GTT GAG TAT ACC AAG AAT; shDCX#4: GTC AGC TCT CAA CAC CTA AGT. The scrambled sequence used as a control (shRandom) was GGA ATC TCA TTC GAT GCA TAC.
Plasmids
DCX plasmid. Mouse wild-type DCX-GFP and FLAG-DCX were kind gifts of Dr. Gregor Eichele, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany (Tsukada et al., 2003) .
Eps15 plasmid. All Eps15-GFP constructs were a kind gift from Dr. Alex Benmerah (Benmerah et al., 1999) .
HA-neurofascin. HA-neurofascin was described previously (Boiko et al., 2007) .
Lamin-cherry. Lamin-cherry was a kind gift from Dr. Bryce Paschal, University of Virginia, Charlottesville, VA.
Rab11-GFP was a kind gift from Dr. Ira Mellman (Genentech).
Cell culture Hippocampal neurons
Primary cultures of hippocampal neurons were obtained from embryonic day 18 (E18) rat hippocampi of either sex as described (Yap et al., 2008a) . Cells were plated on poly-L-lysine coverslips and incubated with DMEM medium with 10% horse serum. After 4 h, the cells were transferred into serum-free medium supplemented with B27 (Invitrogen) and cultured for 9 -12 days in vitro (DIV) . Our hippocampal cultures contained astrocytes and other non-neuronal cell types, but neurotrophins were not added exogenously.
PC12 cells
PC12 cells were maintained in DMEM with 10% horse serum and 5% fetal bovine serum, and all transfections were conducted using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. NGF (from Sigma) was used at 100 ng/ml for 18 -24 h.
COS cells
COS cells were maintained in DMEM plus 10% fetal bovine serum, and all transfections were conducted using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol.
Transfection of neuronal cultures
Neuronal cultures at DIV 9 -12 were transfected using Lipofectamine 2000 with 1 g of DNA, 3 l of Lipofectamine 2000 for 60 -90 min, and washed and incubated for 20 h as described previously (Yap et al., 2008b) . Nucleofection of freshly dissociated neurons was performed using a Nucleofector device (Amaxa Biosystems) according to the manufacturer's instructions.
Immunocytochemistry
Cells were fixed in 2% paraformaldehyde/3% sucrose/PBS in 50% conditioned medium at room temperature for 30 min and quenched in 10 mM glycine/PBS for 10 min. The fixation conditions used do not introduce holes into the overwhelming majority of cells. Coverslips were then blocked in 5% horse serum/1% BSA/PBS Ϯ 0.05% Triton X-100 for 30 min. Antibodies were diluted in 1% BSA/PBS and incubated for 1-2 h, essentially as described previously by Wisco et al. (2003) . Coverslips were mounted in Vectashield (Vector Laboratories) and viewed on a Zeiss Axiophot with a 40ϫ objective. Images were captured with the Orca cooled CCD camera (Hamamatsu) using Openlab software (ImproVision) and processed identically in Adobe Photoshop.
Generation of DCX-GFP mutants Point mutations
Point mutations were introduced using QuikChange site-directed mutagenesis from Stratagene. All mutations were confirmed by sequencing.
FLAG-DCX-R2
Full-length mouse cDNA of DCX resistant to shDCX#2 was generated by changing the targeted sequence of shDCX#2 to TGA CGT GCC TGC ACG ACT TTT by site-directed mutagenesis (Stratagene). The resistant full-length DNA was cloned into pCMV-Tag2 vector (Stratagene) at PstI and XhoI sites to generate pCMV-FLAG-DCX-R2 plasmid.
Duolink assay
The doublecortin/neurofascin proximity was detected in situ using the Duolink II fluorescence kit according to the manufacturer's instructions (Olink Bioscience). Briefly, cultured neurons were fixed and permeabilized and primary antibodies against doublecortin and neurofascin were applied under standard conditions. Duolink secondary antibodies conjugated to oligonucleotides were then added and incubated at 37°C for 1 h in a preheated humidity chamber. This was then followed by ligation and amplification using ligase and polymerase solution that also contained fluorescently labeled oligonucleotides. Signal is only generated if the two antigens are within about 40 nm of each other. After completing the Duolink assay, standard fluorescently labeled secondary antibodies were applied to stain doublecortin and neurofascin.
Endocytosis assay Neurons
Neurons expressing HA-neurofascin for 20 h were incubated with rabbit anti-HA antibodies for 30 min at 37°C and washed several times, and any antibody remaining on the surface was stripped by treatment with MEM, pH 2.0, for 2 min (Fourgeaud et al., 2003) , washed extensively, and returned to the incubator for various amounts of times before fixation in 2% paraformaldehyde/ 3%sucrose/PBS, pH 7.4. Surface HA-NF was visualized with mouse anti-HA antibody and Alexa Fluor 488 goat anti-mouse secondary antibody. Internalized anti-HA antibody was detected by applying Alexa Fluor 568 goat anti-mouse antibody after permeabilization. Permeabilization was achieved with 0.2% Triton X-100 for 10 min at room temperature as by Wisco et al. (2003) . For neurons transfected by nucleofection, endocytosis assay was done at DIV3 by labeled live with mouse anti-NF.
PC 12 cells
For endocytosis experiments, PC-12 cells were plated in 12-well plates onto polylysine-coated coverslips until confluent in feeding medium (10% horse serum, 5% FBS, and 1% Na pyruvate in DMEM). Transfections were carried out with Lipofectamine 2000 (0.6 g of DCX/ 0.4 g of neurofascin plasmids) for 45 min. Lipofectamine was washed away and cells were changed into differentiating medium (1% horse serum, 1% fetal calf serum, and 1% sodium pyruvate in DMEM) containing NGF at 100 ng/ml. Endocytosis assays were performed 24 -48 h later. For endocytosis assays, medium was replaced with medium containing 1:200 rabbit anti-HA antibody for 20 min in 37°C with 250 ng/ml NGF. Acid strip and surface labeling was carried out as described for neurons (see Endocytosis assay).
Immunoprecipitation procedure From HEK293 cells
For immunoprecipitations, transfected HEK293 cells were lysed for 45 min on ice in buffer containing 20 mM Tris-HCl ( pH 7.4), 2 mM EDTA, 2 mM EGTA, 0.1 mM DTT, 100 mM KCl, 10 mM NaF, 1 mM PMSF, 1% Triton X-100 and Complete Protease Inhibitor Cocktail. Lysed cells were centrifuged at 12,000 rpm for 15 min, and the supernatants were then precleared with protein G Sepharose (GE Healthcare) at 4°C for 3 h. Precleared lysates were immunoprecipitated with mouse anti-HA or mouse anti-GFP for 1 h followed by overnight incubation at 4°C with protein G Sepharose. Immunoprecipitates were washed 5ϫ with lysis buffer containing 0.1% Triton X-100 and eluted by 150 mM Tris-HCl ( pH 6.8), 2% SDS, 5% ␤-mercaptoethanol, and 8% glycerol at 95°C. Samples were subjected to SDS-PAGE and Western blot analysis.
From brain membrane fraction
E18 rat brains were homogenized in 3 vol of buffer containing 20 mM HEPES, pH 7.4, 2 mM EDTA, 2 mM EGTA, 0.1 mM DTT, 100 mM KCl, 10 mM NaF, 1 mM PMSF, 0.32 M sucrose, and Halt protease and phosphatase inhibitors on ice and centrifuged at 1000 rpm for 10 min to remove nuclei. The postnuclear supernatant was further centrifuged at 14,000 rpm for 50 min, and the pellet obtained was lysed in homogenization buffer containing 1% Triton X-100 for 45 min on ice. This was followed by centrifugation at 12,000 rpm for 15 
Polarity index
Distal axon, AIS (ankG-positive), and dendrite fluorescence intensities were measured along a 1-pixel-wide line in ImageJ after background subtraction and normalized to length (Boiko et al., 2007) . The AIS polarity of HA-neurofascin was determined by dividing average AIS intensity of HA-neurofascin surface staining by the average intensity of surface HA-neurofascin on dendrites. For endogenous NF staining, AIS intensity measurements are reported without normalizing to dendrite intensity.
Detergent extractions
Detergent extractions of live cells were carried out in BRB80 buffer (80 mM PIPES, 1 mM MgCl 2 , 1 mM EGTA, pH 6.8) or PBSϩϩ buffer (BioWhittaker) with 0.15% Triton X-100 at 37°C for 3 min. Cells were washed once in BRB80 or PBSϩϩ buffer and fixed.
Statistical analysis
Statistical analysis was carried out using Prism software. Datasets were first evaluated as parametric versus nonparametric. Nonparametric datasets were analyzed using Mann-Whitney U test, and parametric datasets were analyzed with Student's t test.
Results

Downregulation of DCX affects surface distribution of NF
Since the significance of the NF-DCX interaction was unknown, we tested whether DCX affected NF distribution in hippocampal neurons after 9 -10 DIV. DCX levels were reduced by expressing short hairpin plasmids directed against rat DCX fused to GFP. One day after transfection with shDCX-GFP plasmids, endogenous DCX was partially but significantly reduced (Fig. 1 A; red, arrow). Four different shDCX plasmids (Fig. 1 B) were tested and all caused significant downregulation of DCX levels in 20 h compared to untransfected cells or to cells expressing the control shRandom plasmid. Average downregulation was between 30 and 40%. Downregulation in a similar range after one day was previously found for electroporation of RNAi into rat embryo cortex (Bai et al., 2003) . We note that the extent of downregulation of DCX in 20 h was variable from cell to cell. For shDCX#2-GFP, 65% of cells significantly downregulated endogenous DCX (average of 63% downregulation), whereas in the other 35% of cells expressing shDCX#2-GFP, endogenous DCX levels were not significantly affected compared to control cells. In the remainder of this work, we used shDCX#2-GFP.
We then tested whether the localization of endogenous neurofascin was affected by downregulation of DCX. Cultured neurons were transfected at DIV7 with either shRandom-GFP or shDCX#2-GFP and the surface pool of endogenous NF stained before fixation at DIV14. Quantification of endogenous DCX staining revealed that only ϳ25% of DCX on average remained after 8 d of shDCX expression (Fig. 1 B) . A small yet significant decrease in AIS intensity of NF was observed in cells expressing shDCX#2-GFP (Fig. 1 D) . We then performed rescue experiments using an shDCX#2-insensitive DCX plasmid containing seven silent point mutations. The phenotype could be partially rescued by cotransfecting resistant DCX (Fig. 1 D) . The AIS surface accumulation of endogenous NF could therefore be modulated by long-term decrease of DCX levels.
Since the components of the AIS, including NF, are very stable once assembled (Zonta et al., 2011) , we wondered whether the small effect observed might be due to the fact that NF localization might not be dynamically modified very much once it reaches the AIS. We thus decided to determine the behavior of HA-NF (NF tagged with an extracellular HA tag) that was acutely expressed for 20 h. This experimental paradigm allowed us to monitor newly synthesized HA-NF that was still trafficking actively. shDCX#2-GFP or shRandom-GFP were cotransfected with HA-NF into DIV9/10 hippocampal neurons, and HA-NF surface distribution was determined by quantifying the average fluorescence intensity along dendrites and along the AIS (Fig. 1C) . Since expression levels of HA-NF vary from cell to cell, the ratio of AIS intensity/dendrite intensity (AIS/D polarity index) was calculated for each cell to quantify the enrichment of HA-NF on the AIS as compared to dendrites (see Materials and Methods; Boiko et al., 2007) . This measure represents the relative AIS enrichment of HA-NF. The AIS/D polarity index fell in the range of 3-9 across a wide range of HA-NF expression levels, with an average AIS/D polarity index of 5-6 in control cells expressing shRandom-GFP (Fig. 1 E; blue triangles). When shDCX#2 was expressed, the average dendrite intensity of HA-NF on the surface was significantly increased (Fig. 1 E; red triangles). As a result, the AIS/D polarity index was significantly decreased (Fig. 1 E, F ) . HA-NF surface levels in the axon were not greatly affected, but a small increase in HA-NF in the distal axon was frequently observed (data not shown). Since it was difficult to unambiguously identify the distal axons of many individual cells, we focused our analysis on dendrites and AIS regions. When we tested all four independent DCX-directed shRNA constructs targeting distinct regions of the DCX transcript, the AIS/D polarity index of HA-NF was significantly reduced for all of them (data not shown). Coexpressing HA-NF, shDCX#2, and resistant DCX-GFP in neurons for 20 h led to statistically significant rescue of the AIS/D polarity index of HA-NF ( Fig. 1 F) . Short-term downregulation of DCX levels therefore led to missorting of acutely expressed HA-NF to the somatodendritic surface and concomitant decrease of the AIS/D polarity index.
We then tested the effects of shDCX on the surface distribution of other axonal receptors. Neither the axonal localization of NgCAM (chick L1; acutely expressed for 20 h with shDCX#2 at DIV9/10) nor the localization of the endogenous AIS-enriched voltage-gated sodium channel (VGSC; shDCX#2 from DIV4-DIV12) was changed by expression of shDCX#2 (Fig. 1G,H ) . The AIS-resident cytoskeletal ankyrinG was also not affected by downregulation of DCX for 7 d (Fig. 1 I) . Decreasing DCX levels thus led to specific mistargeting of HA-NF to dendrites, resulting in reduced relative accumulation on the AIS.
Work by others reported changes in dendritic branching patterns (primarily in young neurons) by shDCX or DCX overexpression or in DCX-/y neurons from knockout animals (Deuel et al., 2006; Cohen et al., 2008) . In our cells, after 20 h of shDCX expression in DIV9/10 neurons, dendrite morphology was not disturbed, and even after 5-7 d of shDCX expression (starting at DIV 7), the extent of the dendritic arbor was still extensive (data not shown).
DCX colocalizes with an intracellular pool of NF.
To determine where in neuronal cells DCX-NF interactions might be taking place, we stained DCX and surface NF (using an antibody directed against an extracellular epitope; Fig. 2 A) in cultured hippocampal neurons and compared them to the localization of total NF (using an antibody against the cytoplasmic tail; Fig. 2 B) . Surface NF (red) was highly enriched on the AIS (arrowhead), as described previously (Hedstrom and Rasband, 2006; Boiko et al., 2007; Dzhashiashvili et al., 2007) . In agreement with previous data (Schaar et al., 2004; Tint et al., 2009) , DCX was found throughout the cell, often enriched in the distal tips of axonal and dendritic processes (aqua). Not surprisingly then, surface NF and DCX were not strikingly colocalized (Fig. 2 A) . In contrast, intracellular NF partially colocalized with DCX in apparent clusters, particularly in dendrites and at dendrite tips (Fig.  2 B; arrows) . A similar colocalization in clustered puncta could also be observed when HA-NF (red, detected with an anticytoplasmic tail antibody) was expressed exogenously in cultured neurons (Fig. 2C) . There was thus a readily detectable intracellular pool of NF, which partially colocalized with DCX. This intracellular pool of NF was widely dispersed throughout the whole cell and did not cluster underneath the AIS.
Next, we determined whether DCX and NF resided in close enough proximity in neurons to give a positive Duolink signal (ϳ40 nm according to the manufacturer; see Materials and Methods). Duolink was performed on DIV10 -12 neurons using a mouse anti-neurofascin cytoplasmic tail (CT)-directed antibody and a rabbit anti-DCX antibody (Fig. 2 B) . Multiple bright dots suggestive of closely apposed binding of the two antibodies were observed (red channel in Fig. 3 A, AЈ) . The positive Duolink signal was particularly apparent in the major dendrites but could also be observed in the soma and less abundantly in axons. The AIS itself was not enriched in labeling (Fig. 3A) . Importantly, no dots were observed if one of the primary antibodies was omitted from the staining procedure (Fig. 3B) . To further verify the specificity of the Duolink signal, we depleted DCX in neurons with shDCX#2-GFP. When shDCX#2 plasmid was expressed in neurons for 5 d (fixed DIV12), the specific labeling efficiency of Duolink between NF and DCX was substantially reduced (red channel in Fig. 3D ) compared to cells expressing a control shRandom plasmid (Fig. 3C) . Dendrites of cells expressing shDCX#2 (green, Fig. 3D ) had little to no DCX staining (blue) and few Duolink dots (red) associated with the transfected (green) dendrites. In contrast, shRandom-expressing neurons displayed Duolink signals indistinguishable from untreated cells (Fig. 3C) . A close-up of dendrites expressing shRandom or shDCX#2 is shown in the small panels. Green arrows indicate dendrites expressing the shRNA constructs (Fig. 3C ,D, small panels) and were mostly devoid of DCX and Duolink signal. Blue arrows indicate the dendrite of a nontransfected neuron still showing DCX (blue) and numerous Duolink dots (Fig. 3D , small panels; red). Line scans of the green dendrites shown in the small panels illustrate the density of red Duolink dots for easier comparison (Fig.  3 E, F ) . Thus specific Duolink labeling between endogenous NF and DCX could be observed, indicating close proximity of the endogenous proteins in dendrites and axons.
Phospho-NF capable of binding DCX is present in hippocampal cultures.
To confirm previous findings that NF was in a complex with a membrane-bound fraction of DCX (Kizhatil et al., 2002) , we performed immunoprecipitations from brain membrane fractions using anti-NF antibody and probing the immunoblot for DCX (Fig. 4 A) . A coimmunoprecipitating band was observed (lane 2) that was not present when nonimmune antibody (lane 1) was used as a control. A membrane fraction from brain therefore contains both NF and DCX, and the two proteins can be immunoisolated as a complex from the membrane fraction.
To test whether phosphoFIGQY-NF (the phospho-form capable of binding DCX) was present in hippocampal cultures, we immunoprecipitated with a pan-NF antibody and probed with a phosphoFIGQY-specific antibody (Kizhatil et al., 2002) . Three prominent NF isoforms were detected (likely corresponding to different splice isoforms) (Fig. 4 B, lane 2) .
Treating 10 DIV cultures with 100 ng/ml NGF for 2 d increased the abundance of phosphoFIGQY-NF. The slowest mobility band, likely NF-186, showed a 2.7-fold increase in phosphoFIGQY reactivity after NGF treatment (Fig. 4 B, compare lanes 2 and 3). PhosphoFIGQY reactivity was thus easily detected in untreated cultures (lane 2), likely due to the presence of growth factors in the medium, and levels were further increased by NGF.
Expression of DCX mutants deficient for NF binding interfere with HA-NF enrichment on the AIS.
Since reduction of DCX levels decreased the relative AIS enrichment of HA-NF (Fig. 1) , we wondered whether expression of a DCX mutant that no longer bound NF affected the relative AIS enrichment of HA-NF. We therefore created a point mutant in DCX previously shown to weaken the interaction of DCX with neurofascin fivefold (Kizhatil et al., 2002 ; patient mutation DCX-G253D; Fig. 4C ) and tested its ability to coimmunoprecipitate with HA-NF. Wild-type DCX-GFP coimmunoprecipitated with HA-NF from HEK293 cells (Fig. 4 D, lane 2, arrow) . In contrast, coimmunoprecipitation of DCX-G253D-GFP with HA-NF was greatly reduced (Fig. 4D, lane 3) .
When DCX-G253D-GFP was expressed with HA-NF in neurons, the relative AIS enrichment of HA-NF was decreased compared to GFP as control (Fig. 5B,C,E,F) . The decrease was due to a significant increase in average somatodendritic fluorescence of surface HA-NF (Fig. 5B) . Coexpression of wild-type DCX-GFP, on the other hand, did not change the relative AIS enrichment of HA-NF (Fig. 5A,C,D,F) . The patient mutation DCX-G253D, therefore, acted in a dominant-negative manner to mislocalize HA-NF.
We then tried to analyze the localization of endogenous NF in DIV10 -14 cells expressing WT-DCX-GFP, DCX-G253D-GFP, or GFP. We did not observe any effects of expressing any of the constructs for 20 h on endogenous NF localization, consistent with the slow turnover of NF at the AIS. When we expressed the DCX-G253D for longer periods of time (7 d), we started to see changes in the morphology of neurons expressing DCX-G253D, indicative of poor health. Endogenous NF localization could therefore not be reliably analyzed.
DCX-G253D is still bound along microtubules in cells.
Since the best-characterized cellular activity of DCX is microtubule binding and bundling (Liu, 2011) , we asked whether DCX-G253D-GFP still bound to microtubules in cells or whether the HA-NF mislocalization phenotype correlated with lack of microtubule binding activity. For this purpose, we used a previously established "in-cell" binding assay in which live cells were extracted in 0.15% Triton X-100 in microtubule-stabilizing buffer (BRB80) before fixation . The ability of DCX to remain associated with microtubules after live detergent extraction was then determined by immunostaining. MAP2 was used to counterstain dendritic microtubules (red). In agreement with previous work, DCX-GFP (Fig. 6 AЈ) remained detergent-resistant, presumably by binding to microtubules. We then performed the same extractions on neurons expressing DCX-G253D-GFP (Fig. 6B,BЈ) . DCX-G253D-GFP could be detected brightly in neurons without extraction (Fig. 6B) or after extraction in BRB80 (Fig. 6BЈ) . Surprisingly, DCX and DCX-G253D were more resistant to extractions than MAP2 itself, whose staining was frequently diminished.
To demonstrate that detergent-resistant DCX remained bound to microtubules rather than other insoluble cytoskeletal 1 and 3) or not (lane 2), and membrane fractions were prepared and used for immunoprecipitation with control IgG (lane 1) or anti-neurofascin (NF) antibody (lanes 2 and 3), and the immunoprecipitates were probed with anti-phosphoFIGQY antibody. PhosphoFIGQY could be detected even without additional NGF, but NGF treatment increased the levels of phospho-FIGQY. MW, Molecular weight. C, Diagram of DCX-GFP indicating the DC repeats and the positions of the G253 and R89 patient mutations. D, HEK293 cells were transfected with HA-NF and GFP (lane 1), DCX-GFP (lane 2), or DCX-G253D-GFP (lane 3). Lysates were prepared and used for WB against HA or GFP or used for IP with anti-HA antibody. DCX-GFP was efficiently immunoprecipitated, whereas DCX-G253D-GFP was not (arrow).
components, we repeated the extractions in COS7 cells where individual microtubules could be easily resolved. We first validated the detergent extractions in COS7 cells and found that microtubules (blue) and F-actin (red) remained intact after detergent extraction in BRB80 (Fig. 6C) . To confirm that detergent resistance was attributable to microtubule binding rather than microfilament binding, we used a microtubule-destabilizing buffer (PBS ϩϩ ) for detergent extractions in which microtubules (blue) were not stably maintained and thus lost, whereas microfilaments (F-actin, red) remained intact (Fig. 6 D) . When DCX-GFP was expressed in COS7 cells and then extracted in BRB80, detergent-resistant DCX-GFP colocalized with splayed individual microtubules (Fig. 6 Ea) . In addition, DCX-GFP induced thick microtubule bundles (Fig. 6 Eb) in the highly expressing cells, consistent with previous observations . When extractions were performed in PBS ϩϩ , DCX-GFP was not detergent resistant, nor were microtubules (Fig. 6 F) . To identify transfected cells, plasmids encoding lamin-cherry (red) were cotransfected because lamin is detergent resistant, even in PBS ϩϩ . Since the cotransfection rate of two different plasmids in COS7 cells was higher than 80% (data not shown), most of the lamincherry expressing cells were also transfected with DCX-GFP, but lost DCX-GFP during the extractions. Next we tested DCX-G253D in the same assay. We found that DCX-G253D-GFP still decorated microtubules and induced thick bundles (Fig. 6G) . Therefore, DCX-G253D-GFP had not lost microtubule binding or bundling capacity. We note that the detergent extraction assay measures overall microtubule binding but does not assess more subtle changes in the interaction and function of mutant DCX with microtubules. The same caveat exists for in-bulk microtubule binding assays , which are carried out entirely in vitro with purified proteins. These observations raised the possibility that the HA-NF localization defect caused by expression of DCX-G253D-GFP was because it could not bind NF and not because of a defect in microtubule binding.
Overexpression of a microtubule-binding deficient DCX (DCX-R89G) did not cause mislocalization of HA-NF.
The NF-localizing activity of DCX could be disrupted by a NF binding-deficient DCX mutant (see above, Expression of DCX mutants deficient for NF binding interfere with HA-NF enrichment on the AIS), but microtubule binding might be additionally needed. We therefore tested whether a DCX mutant incapable of binding microtubules phenocopied the DCX-G253D phenotype with respect to HA-NF distribution. We predicted that it would only phenocopy if the NF-localizing activity of DCX was dependent on its microtubule-binding activity in addition to its NF-binding activity. If DCX played a role in localizing NF independently of its microtubule-binding activity, a microtubulebinding deficient DCX would not phenocopy DCX-G235D. We therefore generated DCX-R89G-GFP, a previously described patient mutation reported to be incapable of binding microtubules (Kim et al., 2003;  Fig. 4C) , and tested the ability of DCX-R89G-GFP to bind microtubules. We note that DCX-R89G-GFP accumulated at lower levels in non-neuronal cells than WT DCX-GFP (Fig. 7A) . In cells transfected with DCX-R89G-GFP and stained without detergent extraction, DCX-R89G-GFP was diffuse in the cytoplasm and did not colocalize along microtubules (Fig. 7C) . When cells were detergent extracted live in BRB80, DCX-GFP (green) decorated microtubules (red) and caused bundling (Fig. 7D) , whereas DCX-R89G-GFP was not detergent resistant and no staining remained, even though microtubules are stabilized (blue) (Fig. 7E) . Lamin-cherry was used again to identify transfected cells. These experiments confirmed that DCX-R89G was deficient for microtubule-binding.
We then cotransfected DCX-R89G-GFP and HA-NF into hippocampal neurons and determined the AIS/D polarity of surface HA-NF 20 h later. In contrast to DCX-G253D-GFP, DCX-R89G-GFP did not impair localization of HA-NF to the AIS (Fig. 7F ). Lastly, we tested whether DCX-R89G-GFP was still able to bind HA-NF by coimmunoprecipitation from transfected HEK293 cells. HA-NF was still coimmunoprecipitated with DCX-R89G-GFP (Fig. 7B, lane 3) . As expected from the much lower expression levels of DCX-R89G-GFP (Fig. 7A) , less DCX-R89G-GFP was detected in the immunoprecipitate.
HA-NF undergoes endocytosis in hippocampal neurons
Next, we tested whether endocytosis might be involved in the relative accumulation of neurofascin at the AIS. This idea arose because shDCX and DCX-G253D both caused abnormal accumulation of HA-NF on dendrites, suggesting that normally HA-NF might be removed from these places by endocytosis. First, we tested whether NF underwent endocytosis in neurons. Endocytosis of L1, a close family member of NF, is well documented, but endocytosis of NF has not been described. In fact, rat NF lacks the endocytosis motif present in the cytoplasmic tail of L1 (Hortsch, 2000) . Using anti-HA antibody feeding of live neurons expressing HA-NF, endocytosis could be readily detected in about 30% of transfected neurons, with somatodendritic puncta being the most prominent ( Fig. 8A; red) . A significant pool of HA-NF remained stably assembled at the AIS ( Fig. 8A ; green) and did not endocytose within 30 min. To ascertain that the observed puncta corresponded to endosomes, we labeled additionally with several markers for different subsets of endosomes, including early endosomes (EEA1-positive), recycling endosomes (rab11-positive), and late endosomes/ lysosomes (LAMP2-positive). Internalized HA-NF colocalized extensively with EEA1 ( Fig. 8B) and partially with rab11-GFP (Fig.  8C) . Little if any colocalization was observed with LAMP2 after a 90 min chase (Fig. 8D) .
To determine whether endogenous NF could also undergo endocytosis, we carried out endocytosis experiments using NF antibodies. In young neurons (DIV3), endocytosis of NF could be observed in dendrites, soma, and axons (Fig. 8 E; red) . Simultaneous uptake of L1-antibodies was carried out as a positive control. Endocytosed L1 (green) could be detected readily alongside with endocytosed NF (red). NF thus undergoes endocytosis in young neurons. After DIV5, endocytosis of NF became more difficult to detect and less frequent (data not shown). In mature neurons (DIV10 and older), endocytosis of endogenous NF was not observed, indicating that assembled NF is stable at the AIS. Since acutely expressed HA-NF in mature neurons still endocytosed (Fig.  8 A) , we postulate that NF endocytoses most vigorously during its biosynthetic delivery and transport, but is stable once it reaches the AIS.
To test whether endocytosis contributed to AIS localization of NF, we inhibited clathrin-mediated endocytosis in neurons by expressing a dominant-negative Eps15 mutant, E⌬95/295-GFP, which titrates out AP2. An inactive Eps15 mutant lacking the AP2 binding site, Eps15-DIII⌬2-GFP (Benmerah et al., 1999) , was used as a control. The efficacy of endocytosis inhibition by E⌬95/295-GFP was confirmed by using transferrin uptake in neurons (data not shown). Coexpressing the inactive Eps15 mutant Eps15-DIII⌬2-GFP showed normal AIS/D PI values of HA-NF of Ͼ6. In contrast, coexpression of the dominantnegative mutant E⌬95/295-GFP significantly decreased AIS/D PI values for HA-NF (Fig. 8 F) . The effect on endogenous NF could not be determined due to increasing toxicity of the dominantnegative protein after expression for several days. These results suggested that endocytosis contributed to the precise AIS accumulation of NF.
Endocytosis of HA-NF is stimulated by coexpression of DCX-GFP in PC12 cells
Since both inhibition of endocytosis and downregulation of DCX resulted in missorting of HA-NF to dendrites, we wondered whether DCX might be directly involved in HA-NF endocytosis. To test this, we carried out endocytosis experiments in PC12 cells, which do not express DCX endogenously. PC12 cells were transfected with HA-NF, either with or without DCX-GFP, and anti-HA endocytosis assays were carried out 20 h later. HA-NF endocytosis in control cells without DCX-GFP was mostly low (Fig. 9A, top row) . In cells expressing DCX-GFP and HA-NF, many cells (Ͼ50%) showed brightly stained endosomes containing anti-HA antibodies (Fig. 9A, bottom  row) . The extent of endocytosis was then quantified using ImageJ (Yap et al., 2010) . DCX-GFP cells showed significantly increased HA-NF endocytosis on average (Fig. 9B ) compared to control cells not expressing DCX-GFP. DCX was therefore able to increase the endocytosis of HA-NF in PC12 cells. We note that the range of NF endocytosis levels was large, suggesting an apparently nonresponsive population of transfected cells (ϳ30%) that did not show increased levels of HA-NF endocytosis upon DCX overexpression, and a population of highly responsive cells that increased NF endocytosis dramatically. The basis for this variability is currently not known, but it might be due to phosphorylation regulation of DCX itself.
If the increase in endocytosis observed with DCX was due to a direct interaction with HA-NF, the NF binding-deficient mutant DCX-G253D should not be able to boost HA-NF endocytosis in PC12 cells. Indeed, DCX-G253D-GFP did not increase HA-NF endocytosis compared to WT-DCX (Fig. 9B) . Surface expression of HA-NF was quantified independently and was the same for Lysates were prepared and used for Western blotting (WB) against HA or GFP or used for immunoprecipitation (IP) with anti-HA antibody. DCX-GFP was efficiently immunoprecipitated (top panel, arrow). DCX-R89G-GFP was expressed at much reduced levels in the lysate, but could still be detected as a coimmunoprecipitating (co-IP) band (lane 3; arrow). C-E, DCX-R89G-GFP has reduced microtubule-binding capacity. C, COS cells were transfected with GFP, DCX-R89G-GFP, or DCX-GFP, fixed, and stained with anti-GFP antibody. GFP and DCX-R89G-GFP are cytosolic and are not associated with microtubules, whereas DCX-GFP decorates microtubules. D, E, COS cells transfected with DCX-GFP (D) or DCX-R89G-GFP (E) were extracted in BRB80. DCX-GFP (green) localizes along microtubules (red) (D). DCX-R89G-GFP, on the other hand, is not detectable (green) despite the presence of microtubules (blue) (E). Lamin-cherry was cotransfected (red) with DCX-R89G-GFP to mark transfected cells. F, Expression of DCX-R89G-GFP in hippocampal neurons does not lead to mislocalization of surface HA-NF (red). A representative experiment is shown (of three independent experiments). N ϭ 63 cells for GFP, 57 cells for DCX-GFP, and 77 cells for DCX-R89G-GFP. Bars, SEM. The differences are not statistically significant.
DCX-GFP or DCX-G253D-GFP expressing cells (data not
shown). We then tested whether the microtubule bindingdeficient DCX, DCX-R89G, still promoted HA-NF endocytosis, or whether microtubule binding was required for this activity. HA-NF endocytosis was increased significantly by expressing DCX-R89G-GFP in PC12 cells, similar to wild-type DCX-GFP (Fig. 9C) . Thus, to stimulate NF endocytosis, NF-binding but not microtubule-binding activity of DCX was required.
To determine whether DCX-GFP boosted the internalization of a wide range of cargo molecules or whether this effect was selective for HA-NF, we also performed endocytosis assays of L1-myc and transferrin in PC12 cells. Neither L1-myc (Fig. 9D ) nor transferrin endocytosis (Fig. 9E) were significantly increased by the coexpression of DCX-GFP.
Endocytosis of endogenous NF is diminished after downregulation of DCX in neurons
Lastly, we tested whether downregulation of DCX would impact the ability of NF to endocytose in young neurons. NF endocytosis assays were carried out in DIV3 hippocampal neurons plated after electroporation with shRandom-GFP (Fig. 10 A) or shDCX#2-GFP (Fig. 10 B) . Cultures were stained with anti-GFP (green), anti-DCX (blue), and anti-mouse secondary antibodies to detect endocytosed NF (red) (Fig. 10 A, B) . Endocytosis was quantified in transfected neurons (arrow) and compared to untransfected neurons in the same field. The average NF endocytosis levels were significantly reduced in neurons expressing shDCX#2-GFP (Fig. 10C ) compared to untransfected cells or neurons expressing shRandom-GFP. Many untransfected neurons (ϳ40%) that expressed DCX also showed low levels of NF endocytosis. This was similar to our observations in PC12 cells, where we found an apparently nonresponsive population of transfected cells that did not show increased levels of HA-NF endocytosis upon DCX overexpression. We note that our cultures also contained a population of DCX-negative cells that endocytosed NF efficiently. These might correspond to glial cells, which are known to express glial isoforms of NF, such as NF-155 (Sherman et al., 2005; Salzer et al., 2008) . These observations suggested that DCX was capable of boosting neurofascin endocytosis in neurons. Surface HA-NF (green) was stained with mouse anti-HA antibody before fixation and permeabilization. A zoom image of the soma region is shown in the bottom panels, with each channel shown separately. B-D, Costaining of endocytosed HA-NF (red) with markers (green) to early endosomes (EEA1) (B), recycling endosomes (rab11-GFP) (C), and late endosomes/lysosomes (LAMP2) after 90 minute chase D, Zoomed-in regions are shown as single channels in the small panels. Yellow arrows point at colocalizing puncta. E, DIV3 hippocampal neurons were incubated live with antibodies against extracellular domains of NF (red) and L1 (green) for 30 min. Both L1 and NF can be detected in endosomes in the soma as well as along processes. One cell is shown with single channels. F, Dominant-negative Eps15 construct (E⌬95/295-GFP) and an inactive Eps15 construct (Eps15DIII⌬2-GFP) were expressed together with HA-NF for 20 h, and AIS/D polarity index was determined. Inhibition of clathrin-mediated endocytosis with E⌬95/295-GFP decreased AIS localization compared to controls (Eps15DIIID2-GFP). N ϭ 15-30 cells per experiment and condition in three independent experiments. **p Ͻ 0.001; Bars, SEM.
Lastly, since NF endocytosis was most robust in developing neurons (Ͻ DIV7), we wanted to know whether levels of endogenous NF at the AIS in developing neurons were more profoundly affected by downregulation of DCX than in more mature cells (DIV14; Fig. 1D ). Since NF accumulation at the AIS was not extensive for about 1 week in culture (Boiko et al., 2007) and was still variable and incomplete at DIV3/4, we quantified NF levels at the AIS in DIV7 neurons after expression of shRandom or shDCX#2 for 7 d. We observed a significant decrease of NF at the AIS in developing neurons (Fig. 10D ) that was larger than in more mature neurons. DCX levels thus modulate NF localization in developing neurons.
Discussion
DCX is genetically linked to lissencephaly, and most patient mutations map to the DC repeats in the N-terminal portion of DCX (for review, see Salzer, 2003; Liu, 2011) . The best-known biochemical activity of DCX is binding to microtubules via its DC repeats. For these reasons, the emphasis in studying DCX function has been on its microtubulebinding functions. Even though other interactions in addition to microtubules have been reported, their significance for DCX function and lissencephaly are largely unknown.Inthiswork,weexplorethefunctional significance of the interaction of DCX with the cell adhesion receptor neurofascin. This interaction was reported several years ago (Kizhatil et al., 2002) , but its role is not known.
We present evidence that (1) DCX plays a role in modulating neurofascin localization on the plasma membrane in developing neurons; (2) DCX acts by increasing endocytosis from non-AIS regions, such as soma and dendrites; and (3) the effect of DCX on neurofascin endocytosis does not require microtubule binding of DCX.
We thus propose that DCX has additional, microtubule-independent functions such as endocytosis and thereby contributes to finetuning the accumulation of neurofascin on specific areas of the plasma membrane. The rolesofendocytosisandendosomaltrafficking of CAMs in neurodevelopment are increasingly being elucidated (for review, see Winckler and Mellman, 2010) . For instance, endocytosis of N-cadherin and integrin has already been implicated in neuronal migration (Kawauchi et al., 2010; Shieh et al., 2011) . Our work opens the exciting possibility-to be explored in the future-that DCX plays additional microtubule-independent roles such as regulating endocytosis of certain CAMs during neurodevelopment.
A new pathway for modulating neurofascin enrichment at the AIS The AIS is of fundamental importance to neuronal function in at least three distinct ways (for review, see Lasiecka et al., 2009; Ogawa and Rasband, 2008) : first, VGSCs clustered on the AIS enable the initiation of action potentials; second, the AIS creates diffusion barriers for membrane, cytoskeletal, and cytosolic proteins that maintain neuronal polarity; and thirdly, the AIS serves as the postsynaptic site for numerous inhibitory synapses. These features in combination thus make the AIS a crucial determinant for neuronal excitability. Our data suggest that the levels of NF at the AIS can be dynamically regulated during development downstream of neurotrophin signaling. We propose that local signaling of neurotrophins (at non-AIS regions) leads to phosphorylation of the FIGQY motif in the cytoplasmic tail of NF. The phosphorylated FIGQY motif has low affinity for ankyrin, but high affinity for DCX. We previously showed that phospho-FIGQY epitopes were enriched along the axon, with the highest levels at distal portions and reduced phosphoFIGQY staining on the AIS itself (Boiko et al., 2007) . This observation is consistent with a model of local regulation of ankyrin-and DCX-binding capacity of NF. We propose that phosphoFIGQY-NF binds to DCX locally. NF is then endocytosed from the neuronal plasma membrane, especially in soma and dendrites. The endocytic machinery required for this event is not yet clear but may involve AP-2 clathrin adaptors. In mature cells where NF is highly accumulated at the AIS, phosphoFIGQY levels are low, presumably due to activity of a currently unidentified phosphatase. Non-phosphoFIGQY-NF can therefore bind to AIS-resident ankyrinG, thereby stabilizing NF on the AIS. In agreement with this high stability of nonphospho-NF at the AIS, we observed the highest extent of NF endocytosis in developing neurons where NF is not yet highly stabilized and accumulated at the AIS.
The postendocytic fate of NF is also not yet known, but it might involve retrograde transport and degradation or retrograde transport coupled with eventual recycling at the AIS (or elsewhere). These subsequent steps are also likely subject to regulation. It is interesting in this regard that we observed a substantial pool of intracellular NF in dendrites. Given that the effect of DCX depletion on AIS levels of NF is moderate (ϳ25% decrease), but effects on NF endocytosis are large (ϳ4-fold), we propose that initial delivery to the cell surface per se is not regulated by DCX, and additional pathways (including possibly direct delivery to the AIS) are responsible for some of the AIS-resident surface pool of NF. Given the high stability of NF on the cell surface (half-life on the order of 5 d) (Hedstrom et al., 2007; Zhang et al., 2012) , we expect a ϳ50% reduction in NF levels in the time frame of the downregulation experiments. We estimate that the 25% effect observed in our experiment (Fig. 10 D) , therefore, accounts for about half of the maximal effect. The other half of NF trafficking to the AIS appears not sensitive to DCX. We speculate that it might be derived from a nonendosomal pool. The role of DCX in our model is one of a regulated modulator of NF levels and distribution in different plasma membrane domains. Given the predominant developmental expression of DCX, it likely plays a developmental role in NF endocytosis. In adult neurons, we predict that NF surface distribution is not subject to DCXmediated endocytosis and regulation.
Interestingly, Bénédicte Dargent (Université de la Méditerranée, Marseille, France) and coworkers (Brechet et al., 2008) showed that AIS targeting of voltage-gated sodium channels (VGSCs) is also regulated by phosphorylation of its ankyrin-binding site, but in the opposite manner to NF. Phosphorylation of the VGSC ankyrin-binding site increases ankyrin-binding affinity. This phosphorylation event occurs downstream of casein kinase II signaling. Neurons thus use distinct regulatory cascades to target different membrane components to the AIS. Since modulating AIS composition is a potential point for functional regulation of excitability (Grubb and Burrone, 2010; Kuba, 2010; Rasband, 2010) , some of the regulatory mechanisms uncovered by us in this work for NF and by others for ion channels (Brechet et al., 2008; Vacher et al., 2011) might prove important for changing levels of crucial AIS proteins in a graded fashion to regulate excitability. More work in the future will shed light on these potential mechanisms.
A role for DCX in regulated endocytosis in neurodevelopment? DCX is linked to lissencephaly, with surviving patients displaying mental retardation and intractable epilepsy (LoTurco and Bai, 2006; Kerjan and Gleeson, 2007) . Mutations in or the absence of DCX cause major migratory defects of multiple neuronal populations during development. In addition, DCX affects dendritogenesis (Deuel et al., 2006; Cohen et al., 2008) . Two genes closely related to DCX, DCLK1 and DCLK2, have partially redundant functions with DCX. Analysis of double knockout mice for DCX and DCLK1 have uncovered a previously unsuspected role for the DCX proteins in axon outgrowth and dendrite branching and demonstrated aberrant trafficking of synaptic vesicle proteins (Deuel et al., 2006) . Mice lacking both DCX and DCLK2 show hippocampal hyperexcitability resulting in spontaneous seizures, and pyramidal neurons in the hippocampus of these mice have reduced dendritic arbors and inhibitory tone (Kerjan et al., 2009) . What are the molecular mechanisms by which DCX acts in these pathways? The focus has been on DCX as a microtubuleassociated protein, in particular its ability to bind microtubules, to promote microtubule polymerization and stabilize microtubules against disassembly. Exactly what the DCX-mediated microtubule functions are is not fully understood. Interestingly, in several DCX patient mutations, in vitro microtubule-binding per se is preserved , raising the possibility that DCX also acts via other mechanisms (Friocourt et al., 2003) . Besides interactions with microtubules, DCX has several other known binding partners. For instance, it reportedly can bind to LIS1 , itself a lissencephaly gene. LIS1 binds the retrograde motor dynein (Tanaka et al., 2004) . The interaction of DCX with the dynein complex via LIS1 might contribute to the migratory defect of cortical neurons found in DCX mutants.
Several of the other reported defects in DCX deficiencies have led to suggestions that DCX is involved in vesicle trafficking. Defects in synaptic vesicles and synaptic vesicle proteins (such as VAMP2) have all been found (Friocourt et al., 2003; Deuel et al., 2006) . The exact molecular mechanisms of such putative trafficking effects of DCX, though, are not known, nor are the cargos. The Bennett laboratory (Kizhatil et al., 2002) identified DCX as a binding partner of phosphoFIGQY-NF several years ago, but the biological relevance of this interaction has been undefined. Our data support the model that NF endocytoses in a DCX-facilitated fashion. In addition, microtubule binding per se is not required to support NF endocytosis by DCX. Our work thus suggests a new additional role for DCX: promoting NF endocytosis and thus regulating the relative accumulation of NF on soma, dendrites, and the AIS. In addition to the role in AIS maintenance (Zonta et al., 2011) , there might be roles for NF in earlier developmental processes. In vitro, NF modulates axon outgrowth (Pruss et al., 2006) , and in vivo, NF plays a role in guiding GABAergic innervation onto the soma and the AIS (Ango et al., 2004; Kriebel et al., 2011) . Since we observe the most robust endocytosis of NF in young neurons, we speculate that DCX-modulation of NF levels could also play a role in developmental processes. More work is needed to test a potential role for DCX-mediated endocytosis in a developmental system.
